J 2011

Assays for determination of matrix metalloproteinases and their activity

KŘÍZKOVÁ, Soňa, Ondřej ZÍTKA, Michal MASAŘÍK, Vojtěch ADAM, Marie STIBOROVÁ et. al.

Basic information

Original name

Assays for determination of matrix metalloproteinases and their activity

Authors

KŘÍZKOVÁ, Soňa (203 Czech Republic, guarantor), Ondřej ZÍTKA (203 Czech Republic), Michal MASAŘÍK (203 Czech Republic, belonging to the institution), Vojtěch ADAM (203 Czech Republic), Marie STIBOROVÁ (203 Czech Republic), Tomáš ECKSCHLAGER (203 Czech Republic), Grace J. CHAVIS (840 United States of America) and René KIZEK (203 Czech Republic)

Edition

Trends in Analytical Chemistry, 2011, 0165-9936

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10406 Analytical chemistry

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 6.273

RIV identification code

RIV/00216224:14110/11:00056993

Organization unit

Faculty of Medicine

UT WoS

000298621500017

Keywords in English

Activity-based profiling; Cancer; Disease marker; Enzymatic method; Fluorimetric method; Immunochemical method; In-vivo imaging; Matrix metalloproteinase (MMP); Multiple-enzyme/multiple-reagent assay system (MEMRAS); Phage display

Tags

International impact
Změněno: 23/3/2012 13:55, Mgr. Michal Petr

Abstract

V originále

Matrix metalloproteinases (MMPs) are involved in many physiological and pathological processes. Due to their ability to cleave and to remodel components of surrounding tissues, MMPs may affect cell migration, differentiation, growth, inflammatory processes, neovascularization, wound healing, apoptosis, the uterine cycle and many other actions within the body, including those needed for tumorigenesis and other diseases. MMPs can therefore be used as potential markers for detecting various cancers, neurodegenerative, and immune and cardiovascular diseases. Numerous MMP assays were developed for clinical and research purposes, but far more attention has been devoted to understanding their biological functions. Due to differences in methodology, results obtained in various laboratory settings are difficult to compare because of the lack of standards and analyticalmethods of validation. Limits of detection of particularmethods used for identifyingMMPs are also disputable. Enzymatic, immunochemical and fluorimetric methods are particularly suitable for clinical use. In-vivo imaging methods offer many potential advantages in cancer research and diagnostics. Other methods are subject to investigation [e.g., phage display, multiple-enzyme/multiple-reagent assay system (MEMRAS) and activity-based profiling].

Links

NS10200, research and development project
Name: Nádorové markery, jejich stanovení a korelace s karcinomem prostaty
Investor: Ministry of Health of the CR